Diffuse Large B-Cell Lymphoma

被引：612
|
作者：
Sehn, Laurie H. [1 ,2 ]
Salles, Gilles [3 ]
机构：
[1] BC Canc Ctr Lymphoid Canc, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 09期
关键词：
RITUXIMAB PLUS CYCLOPHOSPHAMIDE; NON-HODGKIN-LYMPHOMA; PHASE-III TRIAL; ELDERLY-PATIENTS; RESPONSE ASSESSMENT; SINGLE-ARM; OPEN-LABEL; R-CHOP; CYCLES; MULTICENTER;
D O I：
10.1056/NEJMra2027612
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：842 / 858
页数：17
相关论文
共 50 条
  • [21] Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma
    Coleman, Morton
    Lammers, Philip E.
    Ciceri, Fabio
    Jacobs, Ira A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (04): : 175 - 181
  • [22] Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
    Tilly, Herve
    Morschhauser, Franck
    Sehn, Laurie H.
    Friedberg, Jonathan W.
    Trneny, M.
    Sharman, Jeff P.
    Herbaux, Charles
    Burke, John M.
    Matasar, Matthew
    Rai, Shinya
    Izutsu, Koji
    Mehta-Shah, Neha
    Oberic, Lucie
    Chauchet, Adrien
    Jurczak, Wojciech
    Song, Yuqin
    Greil, Richard
    Mykhalska, Larysa
    Bergua-Burgues, Juan M.
    Cheung, Matthew C.
    Pinto, Antonio
    Shin, Ho-Jin
    Hapgood, Greg
    Munhoz, Eduardo
    Abrisqueta, Pau
    Gau, Jyh-Pyng
    Hirata, Jamie
    Jiang, Yanwen
    Yan, Mark
    Lee, Calvin
    Flowers, Christopher R.
    Salles, Gilles
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04): : 351 - 363
  • [23] Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
    Bartlett, Nancy L.
    Hahn, Uwe
    Kim, Won-Seog
    Fleury, Isabelle
    Laribi, Kamel
    Bergua, Juan-Miguel
    Bouabdallah, Krimo
    Forward, Nicholas
    Bijou, Fontanet
    Macdonald, David
    Portell, Craig A.
    Ghesquieres, Herve
    Nowakowski, Grzegorz
    Yasenchak, Christopher A.
    Patterson, Monica
    Ho, Linda
    Rustia, Evelyn
    Fanale, Michelle
    Jie, Fei
    Kim, Jeong-A
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (09)
  • [24] Genetic Profiling in Diffuse Large B-Cell Lymphoma: The Promise and the Challenge
    Cutmore, Natasha H.
    Krupka, Joanna A.
    Hodson, Daniel J.
    MODERN PATHOLOGY, 2023, 36 (01)
  • [25] Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma
    Roschewski, Mark
    Phelan, James D.
    Wilson, Wyndham H.
    CANCER JOURNAL, 2020, 26 (03): : 195 - 205
  • [26] The current landscape of frontline large B-cell lymphoma trials
    Qualls, David
    Armand, Philippe
    Salles, Gilles
    BLOOD, 2025, 145 (02) : 176 - 189
  • [27] Systematic review of outcomes and patient heterogeneity in relapsed or refractory diffuse large B-cell lymphoma
    Miller, Sally D.
    Lozano-Ortega, Greta
    Mutebi, Alex
    Briggs, Owanate
    Sail, Kavita
    Elliott, Brian
    Kalsekar, Anupama
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (01)
  • [28] Diffuse large B-Cell lymphoma: from novel molecular classifications to tailored targeted therapies
    Lue, Jennifer K.
    Nowakowski, Grzegorz S.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8
  • [29] Upfront therapy for diffuse large B-cell lymphoma: looking beyond R-CHOP
    Hill, Brian T.
    Kahl, Brad
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (09) : 805 - 812
  • [30] Checking in on Lenalidomide in Diffuse Large B Cell Lymphoma
    Goldfinger, Mendel
    Xu, Mina
    Bertino, Joseph R.
    Cooper, Dennis L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (06): : E307 - E311
12345